#lottebiologics — Public Fediverse posts

Lotte Biologics expands partnership with UK's OTTIMO Pharma through new CDMO contract for antibody drug Jankistomig, including both production and process development at Syracuse facility, strengthening dual-site strategy connecting North America and Asia with upcoming Songdo plant completion.
#YonhapInfomax #LotteBiologics #OTTIMOPharma #AntibodyDrug #CDMOContract #Jankistomig #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=121036

Lotte Biologics expands partnership with UK's OTTIMO Pharma through new CDMO contract for antibody drug Jankistomig, including both production and process development at Syracuse facility, strengthening dual-site strategy connecting North America and Asia with upcoming Songdo plant completion.
#YonhapInfomax #LotteBiologics #OTTIMOPharma #AntibodyDrug #CDMOContract #Jankistomig #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=121036

Lotte Biologics expands partnership with UK's OTTIMO Pharma through new CDMO contract for antibody drug Jankistomig, including both production and process development at Syracuse facility, strengthening dual-site strategy connecting North America and Asia with upcoming Songdo plant completion.
#YonhapInfomax #LotteBiologics #OTTIMOPharma #AntibodyDrug #CDMOContract #Jankistomig #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=121036

Lotte Biologics expands partnership with UK's OTTIMO Pharma through new CDMO contract for antibody drug Jankistomig, including both production and process development at Syracuse facility, strengthening dual-site strategy connecting North America and Asia with upcoming Songdo plant completion.
#YonhapInfomax #LotteBiologics #OTTIMOPharma #AntibodyDrug #CDMOContract #Jankistomig #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=121036

Lotte Biologics and SK Pharmteco have signed a strategic LOI to jointly provide ADC-specialized CDMO services, aiming to expand their presence in the global antibody-drug conjugate market.
#YonhapInfomax #LotteBiologics #SKPharmteco #ADC #CDMO #GlobalMarket #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=88171

Lotte Group launches its quarterly 'predictable rolling recruitment' with nine affiliates participating in June, offering 32 job categories and expanding global talent outreach through job fairs in Korea and Vietnam.
#YonhapInfomax #LotteGroup #RollingRecruitment #LotteBiologics #JobFair #TalentAcquisition #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=69917

Lotte Biologics has signed a contract manufacturing agreement with OTTIMO Pharma to produce antibody drug substances at its Syracuse Bio Campus, strengthening its global CDMO presence.
#YonhapInfomax #LotteBiologics #OTTIMOPharma #AntibodyDrug #CDMO #SyracuseBioCampus #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=68343

Lotte Biologics has signed a contract manufacturing agreement with OTTIMO Pharma to produce antibody drug substances at its Syracuse Bio Campus, strengthening its global CDMO presence.
#YonhapInfomax #LotteBiologics #OTTIMOPharma #AntibodyDrug #CDMO #SyracuseBioCampus #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=68343

Lotte Biologics has signed a contract manufacturing agreement with OTTIMO Pharma to produce antibody drug substances at its Syracuse Bio Campus, strengthening its global CDMO presence.
#YonhapInfomax #LotteBiologics #OTTIMOPharma #AntibodyDrug #CDMO #SyracuseBioCampus #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=68343

Lotte Biologics has signed a contract manufacturing agreement with OTTIMO Pharma to produce antibody drug substances at its Syracuse Bio Campus, strengthening its global CDMO presence.
#YonhapInfomax #LotteBiologics #OTTIMOPharma #AntibodyDrug #CDMO #SyracuseBioCampus #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=68343

Lotte Biologics has signed a contract manufacturing agreement with OTTIMO Pharma to produce antibody drug substances at its Syracuse Bio Campus, strengthening its global CDMO presence.
#YonhapInfomax #LotteBiologics #OTTIMOPharma #AntibodyDrug #CDMO #SyracuseBioCampus #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=68343

Lotte Biologics secures first ADC production contract, signaling full operation of its New York facility and expansion into global ADC CDMO market
#YonhapInfomax #LotteBiologics #ADCProduction #CDMOServices #BiotechContract #SyracuseBioCampus #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=60084

SK Bioscience and Lotte Biologics pursue global expansion strategies amid financial challenges, with both companies facing continued performance pressures due to large-scale investments in overseas markets and production facilities.
#YonhapInfomax #SKBioscience #LotteBiologics #GlobalExpansion #OperatingLoss #InvestmentCosts #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=56565

Lotte Holdings to invest 168 billion won in Lotte Biologics' rights offering, aiming to maintain control and boost competitiveness in bio business
#YonhapInfomax #LotteHoldings #LotteBiologics #RightsOffering #BioCampus #CapitalContribution #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=55762